Synergia Lights Up With $10m For Smaller, MRI-Friendly, Rechargeable Neurostim Device
Executive Summary
Belgian Synergia Medical has scored €8.1m ($10.1m) in Series A funding to take the company's vagus nerve stimulation device through to advanced-stage testing before filing for CE marking.
You may also be interested in...
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.